小分子和化合物库
选项
-
重组Kex2蛋白酶CAS号: 99676-46-7种属: 发面酵母(Baker's yeast) Accession #: P13134表达系统: 毕赤酵母 蛋白标签: No tag 内毒素水平: <0.1 EU/μg生物活性: 酶比活≥10U/mg 酶活定义:在 25°C, pH 8. 0 的条件下,每分钟催化 1 μmol 的 Boc-QR R-pNA 转化为产物所需要的酶量为一个酶活单位(U)。
-
-
-
热稳定无机焦磷酸酶种属: 布氏栖热菌(Thermus brockianus) Accession #: A0A1J0LV32表达系统: E. coli生物活性: ≥0.1 U/μL,单位定义:1个活性单位(U)是指在pH 7.2条件下,25℃反应30min,每分钟释放1.0μmole无机正磷酸盐所需要的酶量。SMILES: CC1=C2C(N(CCC2=NN1)C(=O)C=CC3=C(C=CC(=C3F)Cl)N4C=NN=N4)C(=O)CC5=CC=C(C=C5)C(=O)C.CC1=C2C(N(CCC2=NN1)C(=O)C=CC3=C(C=CC(=C3F)Cl)N4C=NN=N4)C(=O)CC5=CC=C(C=C5)C(=O)OC(C)(C)C
-
D-葡萄糖-¹³C₆,1,2,3,4,5,6,6-d₇CAS号: 201417-01-8分子式: 13C6H5D7O6 分子量: 193.15IUPAC Name: (2R,3S,4R,5R)-1,2,3,4,5,6,6-heptadeuterio-2,3,4,5,6-pentahydroxy(1,2,3,4,5,6-13C6)hexan-1-oneSMILES: C(C(C(C(C(C=O)O)O)O)O)OInChIKey: GZCGUPFRVQAUEE-VVZLUFAVSA-NInChI: 1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1/i1+1D,2+1D2,3+1D,4+1D,5+1D,6+1D
-
酮康唑CAS号: 65277-42-1 EC号: 265-667-4分子式: C26H28Cl2N4O4 分子量: 531.43IUPAC Name: 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanoneSMILES: CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)ClInChIKey: XMAYWYJOQHXEEK-OZXSUGGESA-NInChI: 1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAFCAS号: 2050232-20-5SMILES: [Belantamab mafodotin]
-
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 1401812-88-1
-
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: SMCC-DM1CAS号: 1008106-64-6
-
Lutikizumab (anti-IL1a&IL1b)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791411-57-8
-
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: CL2A-SN-38CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
首页
400-620-6333









